Public channel page

A public introduction for advisors and long-term health relationships.

If you work in high-trust, long-cycle client relationships, this page explains where Fern Gene fits, who it suits, and which boundaries should stay explicit.

Fern Gene does not run sequencing, does not make diagnoses, and does not take custody of raw genome files by default.

Live areas

17

Live rules

1,185

Evidence sources

10

Send each client to the right next step

Client already has data

People who already tested with WeGene, BGI, 23andMe, or another provider

These clients should go straight to the existing-data path. You do not need to teach the whole product before they can move.

Send them to the existing-data page

Client still needs sequencing

People who have not bought yet, but want to keep the raw files later

Start with the sequencing path. The key questions are raw files, retrieval, and how they come back to Fern Gene later.

Send them to the sequencing page

Client is still comparing

People still unsure about WeGene, BGI, raw files, privacy, or partner review

The answer pages usually land better than a long product explanation when the client is still comparing options.

Send them to the answers page

Who this fits best

It fits best when the client already tested, or is willing to manage health over time.

The strongest fit is usually not low-intent mass traffic. It is people who already tested, are planning for marriage or pregnancy, care about family history, or want a longer service relationship.

  • People who already tested with WeGene, BGI, 23andMe, or another provider
  • People planning for marriage, pregnancy, or family-history review
  • People who want to keep one test useful over time

How an advisor can use it

It fits long-term follow-up better than an instant answer.

A better use is client education, ongoing follow-up, and a handoff into partner referral rather than packaging it like a report that solves everything on the spot.

  • Explain why raw files are worth keeping
  • Explain why interpretation can keep changing
  • Then hand off into partner referral, import, and longer-term follow-up

What must stay out of bounds

What should stay off-limits.

This path can help explain long-term value, but it cannot imply diagnosis, treatment effect, underwriting outcomes, or anything else beyond the product boundary.

  • It does not replace clinical diagnosis or physician advice
  • It does not promise underwriting, claims outcomes, or disease conclusions
  • Partner referral tracks status only and does not store raw files